Jonathan E Walker

Summary

Publications

  1. ncbi Recent advances in quantitative EEG as an aid to diagnosis and as a guide to neurofeedback training for cortical hypofunctions, hyperfunctions, disconnections, and hyperconnections: improving efficacy in complicated neurological and psychological disorder
    Jonathan E Walker
    Neurotherapy Center of Dallas, Dallas, TX 75230, USA
    Appl Psychophysiol Biofeedback 35:25-7. 2010
  2. ncbi Power spectral frequency and coherence abnormalities in patients with intractable epilepsy and their usefulness in long-term remediation of seizures using neurofeedback
    Jonathan E Walker
    Neurotherapy Center of Dallas, 12870 Hillcrest, Dallas, Texas 75230, USA
    Clin EEG Neurosci 39:203-5. 2008
  3. ncbi Using QEEG-guided neurofeedback for epilepsy versus standardized protocols: enhanced effectiveness?
    Jonathan E Walker
    Neurotherapy Center of Dallas, Dallas, TX, USA
    Appl Psychophysiol Biofeedback 35:29-30. 2010
  4. ncbi QEEG-guided neurofeedback for recurrent migraine headaches
    Jonathan E Walker
    Neurotherapy Center of Dallas, 12870 Hillcrest, Suite 201, Dallas, Texas 75230, USA
    Clin EEG Neurosci 42:59-61. 2011
  5. ncbi Neurofeedback treatment of epilepsy
    Jonathan E Walker
    Neurotherapy Center of Dallas, 12870 Hillcrest Road, Suite 201, Dallas, TX 75230, USA
    Child Adolesc Psychiatr Clin N Am 14:163-76, viii. 2005
  6. ncbi A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis
    Jonathan E Walker
    Board Certified Psychiatry and Neurology, Dallas, TX 75230, USA
    Mult Scler 11:149-58. 2005

Detail Information

Publications6

  1. ncbi Recent advances in quantitative EEG as an aid to diagnosis and as a guide to neurofeedback training for cortical hypofunctions, hyperfunctions, disconnections, and hyperconnections: improving efficacy in complicated neurological and psychological disorder
    Jonathan E Walker
    Neurotherapy Center of Dallas, Dallas, TX 75230, USA
    Appl Psychophysiol Biofeedback 35:25-7. 2010
    ..Use of the modular activation/coherence model (Walker et al. in J Neurother 11: 25-44, 2007) provides a framework for correcting the slow or fast modular dysfunctions, as well as normalizing connectivity using coherence training...
  2. ncbi Power spectral frequency and coherence abnormalities in patients with intractable epilepsy and their usefulness in long-term remediation of seizures using neurofeedback
    Jonathan E Walker
    Neurotherapy Center of Dallas, 12870 Hillcrest, Dallas, Texas 75230, USA
    Clin EEG Neurosci 39:203-5. 2008
    ..When most of the power and coherence abnormalities were normalized with neurofeedback training, all the patients became seizure-free; 76% no longer required an anticonvulsant for seizure control...
  3. ncbi Using QEEG-guided neurofeedback for epilepsy versus standardized protocols: enhanced effectiveness?
    Jonathan E Walker
    Neurotherapy Center of Dallas, Dallas, TX, USA
    Appl Psychophysiol Biofeedback 35:29-30. 2010
    ..This article briefly reviews some of the past EEG treatments of epilepsy and discusses how QEEG may potentially enhance effectiveness of this approach. Several cases are presented in support of this approach...
  4. ncbi QEEG-guided neurofeedback for recurrent migraine headaches
    Jonathan E Walker
    Neurotherapy Center of Dallas, 12870 Hillcrest, Suite 201, Dallas, Texas 75230, USA
    Clin EEG Neurosci 42:59-61. 2011
    ..QEEG-guided neurofeedback appears to be dramatically effective in abolishing or significantly reducing headache frequency in patients with recurrent migraine...
  5. ncbi Neurofeedback treatment of epilepsy
    Jonathan E Walker
    Neurotherapy Center of Dallas, 12870 Hillcrest Road, Suite 201, Dallas, TX 75230, USA
    Child Adolesc Psychiatr Clin N Am 14:163-76, viii. 2005
    ..A model of how neurofeedback might raise the seizure threshold is then presented. Clinical experience using a quantitative EEG-guided approach is described, including a representative case study...
  6. ncbi A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis
    Jonathan E Walker
    Board Certified Psychiatry and Neurology, Dallas, TX 75230, USA
    Mult Scler 11:149-58. 2005
    ..These findings indicate a significant effect of pirfenidone on clinical disability and bladder function for secondary progressive MS patients. A major multicentre, double-blind, randomized, controlled trial is justified...